BioGaia and Ferring extend licensing arrangement

Swedish probiotics specialist BioGaia has strengthened its relationship with biopharma group, Ferring Pharmaceuticals, via new licensing agreements that will see the Swiss firm distributing BioGaia products in European and Middle East countries.

Ferring has acquired the exclusive rights to sell BioGaia's Probiotic Drops in Ireland as well as the rights to sell BioGaia's Probiotic Drops and Tablets in Bahrain, Yemen, Qatar, Oman, Kuwait and United Arab Emirates.

"We are very happy to again expand the contract with Ferring in to these interesting markets. Ferring is taking the BioGaia brand to markets we have not been before and it is yet another step in our effort to build a global probiotic brand," said BioGaia president, Peter Rothschild.

Related Topics

Suppliers

Related news

In search of probiotics' oral potential

UK-based Leatherhead Food International (LFI) is seeking commercial interest for a research project that will explore the potential of probiotics to deliver oral health benefits.

Chewable probiotics gain momentum

Chewable probiotic supplements are emerging as an area of potential in the industry, as manufacturers broaden their scope into new categories, according to a major ingredients firm.